NAD+ Longevity Drink  ·  Founding Member Access Open

Your NAD⁺ has been
declining since
your 30s.

SIRTS is a daily RTD beverage built around Nicotinamide Riboside — the most direct, clinically studied precursor for restoring NAD⁺ levels. One formula. One non-negotiable daily ritual.

Founding member spots763 of 1,000 remaining
Secure your founding spot

No commitment until you confirm your order

RD
MK
JL
+
237 founding members have already reserved
SIRTS NAD+ Cellular Energy
NR-Based NAD+ Formula
Sirtuin Activation
12 fl oz / 355ml
Daily Ritual
Clinically Studied
NAD+ Restoration
1,000 Founding Members Only
NR-Based NAD+ Formula
Sirtuin Activation
12 fl oz / 355ml
Daily Ritual
Clinically Studied
NAD+ Restoration
1,000 Founding Members Only
~50%
NAD⁺ DECLINE BY 40S
Measured against baseline levels in your 20s. Documented, accelerating, and addressable.
7
SIRTUIN LONGEVITY PROTEINS
All NAD⁺-dependent. All requiring consistent daily substrate to activate their function.
NR
CORE PRECURSOR
Nicotinamide Riboside. Peer-reviewed, bioavailable, proven to raise whole-blood NAD⁺ in humans.
01 — The product

One formula.
One daily ritual.

Built around the most direct, clinically studied NAD⁺ precursor. No complexity. Just the daily ritual that works.

NAD+
NAD+
Cellular Energy
NAD⁺ restoration targeting cellular repair pathways and sirtuin activation. The daily ritual for the longest game.
02 — The formula

Every ingredient
earns its place.

250mg of Nicotinamide Riboside per can. Not a trace dose. Not a marketing number. The full clinical threshold, paired with a cofactor stack built to support the NAD⁺ synthesis pathway — not to pad the label.

Nicotinamide Riboside (NR)
250 mg
Core NAD⁺ precursor. Clinically studied. Converts intracellularly to NAD⁺.
L-Theanine
100 mg
Cognitive clarity without stimulation.
Magnesium (as glycinate)
50 mg
NAD⁺ pathway cofactor. Supports recovery and cellular signaling.
Riboflavin (B2)
1.7 mg
Cofactor in the NAD⁺ synthesis pathway.
Niacin (as niacinamide, B3)
10 mg
Complementary NAD⁺ precursor at sub-flush dose.
Zinc (as gluconate)
5 mg
Sirtuin activation cofactor.
Sodium
~35 mg
Electrolyte baseline for stability and absorption.
Zero sugar. ~10–15 kcal. Lightly carbonated. ChromaDex-sourced NR (Tru Niagen®).
03 — The mechanism

The science is settled.
The format wasn't.

A decade of peer-reviewed research on NAD⁺ precursors. What hasn't existed is a daily format designed around behavioral compliance — something you actually reach for every day. SIRTS is that format.

01

NAD⁺ declines with age

By your 40s, NAD⁺ has dropped roughly 50% versus your 20s. This molecule drives energy production, DNA repair, and circadian function. Its decline may be a primary driver of aging — not just a symptom.

02

Sirtuins need NAD⁺

Seven longevity proteins — sirtuins — depend entirely on NAD⁺ to function. They regulate gene expression, metabolic efficiency, and stress response. No substrate, no activation.

03

NR restores the signal

Nicotinamide Riboside crosses into cells intact and converts directly to NAD⁺. Human clinical trials confirm significant whole-blood NAD⁺ elevation with consistent oral NR supplementation.

04

Format drives compliance

Capsule compliance drops to 40–60% at 90 days. NAD⁺ precursors require daily dosing to work. SIRTS is engineered for compliance by making the ritual worth keeping.

04 — Who it's for

Built for people who
take the long view.

01
The performance professional
You've optimized sleep, HRV, and diet. You track biomarkers. SIRTS is the daily NAD⁺ input formulated for your standard, not the mass market's.
02
The longevity reader
You've read Attia and Sinclair. You understand NAD⁺ decline. You've been waiting for a delivery format that doesn't feel like medicine.
03
The 40s inflection point
You feel the shift — energy, recovery, cognitive sharpness. The decline is documented and addressable. This is the decade where intervention compounds most.
04
The ritual seeker
A pill is an obligation. SIRTS is a daily object worth reaching for — which is exactly how you build the consistency that makes the compound work.
Investor opportunity

We're raising $400K
to bring SIRTS to market.

Seed round via SAFE. $3.5M valuation cap. $500 minimum check. The earliest opportunity to back a category-defining longevity RTD brand — before product, before revenue, before the market catches up.

$400K
Raise target
$3.5M
Valuation cap
$500
Min. check
No commitment. Full deck available on request.
RAISE PROGRESS
$45,000
committed of $400,000 goal
12 investors have expressed interest
SAFE instrument
YC standard terms
Open to all investors
No maturity date

The $400K raise covers co-packer deposit, first production run, regulatory filings, and launch marketing. No runway padding — this is a targeted round to get to first shipment.

Founding member access · 1,000 spots only

Secure your spot
before launch.

Choose your founding member configuration. Early pricing locked in — never available again after launch.

No credit card required to reserve your spot